When does purchase order financing fit?
The situation is specific. A distributor or manufacturer holds a confirmed order it cannot fund: the order is larger than the working capital available, the supplier wants paying before the customer will pay, and the real choice is financing the order or declining it. Purchase order finance funds the making of the sale. Factoring and receivables finance fund the waiting after it. An asset-based facility funds the pattern rather than the transaction.
That placement is the cleanest way to choose between them. If the cash gap sits before delivery, it is purchase order financing. If it sits after the invoice is raised, it is factoring. If the gap recurs order after order, it is a working-capital facility, and paying transaction pricing for a standing need is the most common expensive mistake in this product.
Funders underwrite the transaction more than the borrower. The end customer's credit, because repayment ultimately arrives from it. The supplier's reliability, because the funder often pays the supplier directly. The margin inside the order, because the funding cost has to fit within it. And the logistics between the three. The evidence is the purchase order itself, the supplier terms, and the customer's payment history, assembled in days rather than weeks, which is part of what the borrower is paying for.
What does purchase order financing cost right now?
It is priced per period rather than per year. Published rates run 1.8% to 6% of order or invoice value per month, which the same lender converts to an effective annual equivalent of 30% to 80% and above (Crestmont Capital, Allan Garfinkle, 31 March 2026). A trade financier publishing on the same product quotes the same 1.8% to 6% per month converting to 20% to 75% on an annual basis, describes 2% to 3% per month as a reasonable rate, and states advances of 80% to 90% of order value over a cycle of 30 to 90 days (Drip Capital, Romina Mohan Gopalan, 25 April 2026).
Both conversions come with the same caveat, and it is a fair one: an annual rate on money outstanding for six weeks overstates what the transaction costs in dollars. The annualized figure is not the bill. It is the comparison, and it is the only way to set this product against a facility that prices by the year. Both numbers belong in the decision, the fee in dollars for the transaction and the rate for the comparison against everything else the business could do instead.
Which end of those ranges a borrower is quoted moves with the funder's reading of the same four things it underwrites, so a single quote carries very little information about the market. Running two or three funders against the same order file is what converts a quote into a price, and it is the same discipline that applies to a facility ten times the size.
Does the fee fit inside the margin?
This is the borrower's test, and it is not the test the market publishes. Funders state margin requirements as qualification criteria: gross margins of at least 15% to 20% on the funded order, with 20% and above described as the best candidates and the product called not economically viable below 15% (Crestmont Capital, 31 March 2026), and at least 15% to 20% measured after financing fees are deducted (Drip Capital, 25 April 2026). Those numbers answer whether a funder will take the transaction. They do not answer whether the borrower should.
The borrower's version sets the total fee against the gross profit on the order rather than against the order value. On a 30% gross margin, a 4% total fee consumes about 13% of the gross profit on that transaction, which is usually worth paying against the alternative of declining the order and whatever the customer relationship is worth beyond it. That is our own arithmetic on stated assumptions rather than a market figure. The trade stops making sense as the fee approaches half the margin, and the closer it gets the more the decision rests on the value of the customer rather than the value of the order.
Two things break the arithmetic after commitment rather than before it. Costs outside the headline rate: fees that escalate with the period, administrative and processing charges, and a cycle that runs longer than the quote assumed. And margin that was never really there, because the order was priced before the financing was. Pricing the order with the funding cost inside it is the discipline that keeps this test honest, and it is available only to a business that thought about financing before it quoted.
When should this become something cheaper?
Purchase order financing is transaction pricing, and transaction pricing is the right answer to a spike. The test for whether the need has changed shape is repetition: a second and a third order funded the same way is not an emergency, it is a pattern, and a pattern deserves a facility rather than a sequence of transactions. The facility's real test is that second order, where the arrangement either becomes a programme or stays an expensive habit.
The ladder runs in one direction. Purchase order finance funds production against the order. Factoring or receivables finance funds the invoice the delivery creates, at lower cost because the risk is a receivable rather than a performance. An asset-based facility funds receivables and inventory together against a borrowing base, priced well inside either, and sized on history rather than on a single order. Each step down costs less and asks more: a longer record, cleaner reporting, and collateral a lender can measure and monitor.
So the honest conclusion is sometimes that a borrower should use this product once while building toward the facility that replaces it, and sometimes that it should not use it at all. A business with a fundable balance sheet almost always does better inside a facility than inside a run of transactions. Where the two run alongside each other, the agreement between the funders over who has claim to what is negotiated at the outset, and that drafting decides how the arrangement behaves on the order that goes wrong.